[1] 陈星月,陈栋,陈春慧,等.中国创伤性脊髓损伤流行病学和疾病经济负担的系统评价[J].中国循证医学杂志,2018,18(2):143-150.
[2] JENDELOVA P. Therapeutic Strategies for Spinal Cord Injury. Int J Mol Sci. 2018;19(10):3200.
[3] HAN Y, LI X, ZHANG Y, et al. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019;8(8):886.
[4] MUKAI T, TOJO A, NAGAMURA-INOUE T. Mesenchymal stromal cells as a potential therapeutic for neurological disorders. Regen Ther. 2018;9:32-37.
[5] FUNES SC, RIOS M, ESCOBAR-VERA J, et al. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154(2):186-195.
[6] FAN B, WEI Z, YAO X, et al. Microenvironment Imbalance of Spinal Cord Injury. Cell Transplant. 2018;27(6):853-866.
[7] ANWAR MA, AL SHEHABI TS, EID AH. Inflammogenesis of Secondary Spinal Cord Injury. Front Cell Neurosci. 2016;10:98.
[8] TRAN AP, WARREN PM, SILVER J. The Biology of Regeneration Failure and Success After Spinal Cord Injury. Physiol Rev. 2018;98(2):881-917.
[9] ORR MB, GENSEL JC. Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses. Neurotherapeutics. 2018;15(3):541-553.
[10] FLEMING JC, NORENBERG MD, RAMSAY DA, et al. The cellular inflammatory response in human spinal cords after injury. Brain. 2006;129(Pt 12): 3249-3269.
[11] KUMAR H, CHOI H, JO MJ, et al. Neutrophil elastase inhibition effectively rescued angiopoietin-1 decrease and inhibits glial scar after spinal cord injury. Acta Neuropathol Commun. 2018;6(1):73.
[12] COFANO F, BOIDO M, MONTICELLI M, et al. Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy. Int J Mol Sci. 2019;20(11):2698.
[13] KOZLOWSKA U, KRAWCZENKO A, FUTOMA K, et al. Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues. World J Stem Cells. 2019;11(6):347-374.
[14] NTEGE EH, SUNAMI H, SHIMIZU Y. Advances in regenerative therapy: A review of the literature and future directions. Regen Ther. 2020;14:136-153.
[15] FU Q, ZHANG Q, JIA LY, et al. Isolation and Characterization of Rat Mesenchymal Stem Cells Derived from Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood. Cells Tissues Organs. 2015 -2016;201(6): 412-422.
[16] RAJABZADEH N, FATHI E, FARAHZADI R. Stem cell-based regenerative medicine. Stem Cell Investig. 2019;6:19.
[17] LUZ-CRAWFORD P, DJOUAD F, TOUPET K, et al. Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation. Stem Cells. 2016;34(2): 483-492.
[18] QU J, ZHANG H. Roles of Mesenchymal Stem Cells in Spinal Cord Injury. Stem Cells Int. 2017;2017:5251313.
[19] 王国毓,程志坚,杨保辉,等.脊髓损伤后硫酸软骨素蛋白多糖及GFAP表达的变化[J].生物骨科材料与临床研究,2020,17(1): 43-46.
[20] MUKHAMEDSHINA YO, GRACHEVA OA, MUKHUTDINOVA DM, et al. Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury. Neural Regen Res. 2019;14(2):227-237.
[21] ZENG X, MA YH, CHEN YF, et al. Autocrine fibronectin from differentiating mesenchymal stem cells induces the neurite elongation in vitro and promotes nerve fiber regeneration in transected spinal cord injury. J Biomed Mater Res A. 2016;104(8):1902-1911.
[22] FU Q, LIU Y, LIU X, et al. Engrafted peripheral blood-derived mesenchymal stem cells promote locomotive recovery in adult rats after spinal cord injury. Am J Transl Res. 2017;9(9):3950-3966.
[23] MALDONADO-LASUNCIÓN I, VERHAAGEN J, OUDEGA M. Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair. Neurotherapeutics. 2018;15(3):578-587.
[24] 陈龙.外周血间充质干细胞诱导巨噬细胞极化与重编程的体外研究[D]. 遵义:遵义医学院.2016.
[25] 高弘斐,张潜,陈龙,等.间充质干细胞与巨噬细胞共培养体系的细胞因子表达模式研究[J].免疫学杂志,2017,33(11): 930-936.
[26] ZHENG YH, DENG YY, LAI W, et al. Effect of bone marrow mesenchymal stem cells on the polarization of macrophages. Mol Med Rep. 2018;17(3): 4449-4459.
[27] BADNER A, VAWDA R, LALIBERTE A, et al. Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury. Stem Cells Transl Med. 2016;5(8):991-1003.
[28] 曾园山.电针督脉经穴联合成体干细胞移植策略在修复脊髓损伤中的研究进展[J].中山大学学报(医学科学版),2017,38(6):801-807.
[29] ZHANG S, CHUAH SJ, LAI RC, et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16-27.
[30] JOO HS, SUH JH, LEE HJ, et al. Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent. Int J Mol Sci. 2020;21(3):727.
[31] ELAHI FM, FARWELL DG, NOLTA JA, et al. Preclinical translation of exosomes derived from mesenchymal stem/stromal cells. Stem Cells. 2020;38(1): 15-21.
[32] SUN G, LI G, LI D, et al. hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation. Mater Sci Eng C Mater Biol Appl. 2018;89:194-204.
[33] LIU W, WANG Y, GONG F, et al. Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes. J Neurotrauma. 2019;36(3):469-484.
[34] LI D, ZHANG P, YAO X, et al. Exosomes Derived From miR-133b-Modified Mesenchymal Stem Cells Promote Recovery After Spinal Cord Injury. Front Neurosci. 2018;12:845.
[35] 陈刚,吴骏,于天飞.干细胞结合生物材料治疗脊髓损伤的研究进展[J].生物学教学,2016,41(12): 11-13.
[36] WANG N, XIAO Z, ZHAO Y, et al. Collagen scaffold combined with human umbilical cord-derived mesenchymal stem cells promote functional recovery after scar resection in rats with chronic spinal cord injury. J Tissue Eng Regen Med. 2018;12(2):e1154-e1163.
[37] CARON I, ROSSI F, PAPA S, et al. A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. Biomaterials. 2016;75:135-147.
[38] KANG KN, LEE JY, KIM DY, et al. Regeneration of completely transected spinal cord using scaffold of poly(D,L-lactide-co-glycolide)/small intestinal submucosa seeded with rat bone marrow stem cells. Tissue Eng Part A. 2011;17(17-18):2143-2152.
[39] YOUSEFIFARD M, NASSERI MALEKI S, ASKARIAN-AMIRI S, et al. A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019;32(2):269-284.
[40] 孙佳慧,林欣怡,邹剑龙,等.神经组织工程技术治疗脊髓损伤的研究进展[J].解剖学研究,2016,38(6):480-483.
[41] CHEN L, ZHANG Q, CHEN QH, et al. Combination of G-CSF and AMD3100 Improves the Anti-inflammatory Effect of Mesenchymal Stem Cells on Inducing M2 Polarization of Macrophages Through NF-κB-IL1RA Signaling Pathway. Front Pharmacol. 2019;10:579.
[42] CHAUBEY S, THUESON S, PONNALAGU D, et al. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res Ther. 2018;9(1):173.
[43] WANG K, SHI YJ, SONG ZL, et al. Regulatory effect of rat bone marrow mesenchymal stem cells on Treg/Th17 immune balance in vitro. Mol Med Rep. 2020;21(5):2123-2130.
[44] WANG D, HUANG S, YUAN X, et al. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5):423-431.
[45] KIM C, KIM HJ, LEE H, et al. Mesenchymal Stem Cell Transplantation Promotes Functional Recovery through MMP2/STAT3 Related Astrogliosis after Spinal Cord Injury. Int J Stem Cells. 2019;12(2):331-339.
[46] IP WKE, HOSHI N, SHOUVAL DS, et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017; 356(6337):513-519.
[47] OUYANG W, RUTZ S, CRELLIN NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71-109.
[48] 刘克勋,霍洪军,赵岩,等.间充质干细胞移植治疗脊髓损伤的进展及发展趋势[J].中国组织工程研究,2018,22(21):3410-3416.
[49] KAKABADZE Z, KIPSHIDZE N, MARDALEISHVILI K, et al. Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury. Stem Cells Int. 2016;2016:6768274.
[50] MENDONÇA MV, LAROCCA TF, DE FREITAS SOUZA BS, et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. 2014;5(6):126.
[51] DAI G, LIU X, ZHANG Z, et al. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury. Brain Res. 2013;1533:73-79.
[52] 刘静,韩冬梅,薛梅,等.脐带间充质干细胞鞘内注射治疗脊髓损伤的长期临床观察[J].组织工程与重建外科,2017,13(6): 313-317.
[53] YAO L, HE C, ZHAO Y, et al. Human umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injury: Electrophysiological changes and long-term efficacy. Neural Regen Res. 2013;8(5):397-403.
[54] 张陆,刘志昂,姜岩,等.脐带间充质干细胞移植治疗急性脊髓损伤的临床价值[J].中国脊柱脊髓杂志,2019,29(3):254-260.
[55] RA JC, SHIN IS, KIM SH, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011;20(8):1297-1308.
[56] HUR JW, CHO TH, PARK DH, et al. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial. J Spinal Cord Med. 2016;39(6):655-664.
[57] AMR SM, GOUDA A, KOPTAN WT, et al. Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients. J Spinal Cord Med. 2014;37(1):54-71.
[58] ZHAO Y, TANG F, XIAO Z, et al. Clinical Study of NeuroRegen Scaffold Combined With Human Mesenchymal Stem Cells for the Repair of Chronic Complete Spinal Cord Injury. Cell Transplant. 2017;26(5):891-900.
[59] 唐玺和,范益民,蓝胜勇.细胞与生物材料联合治疗脊髓损伤的研究现状[J].中国比较医学杂志,2018, 28(6):127-130.
[60] 秦丰伟,焦锋,张兆飞,等.淫羊藿苷联合骨髓间充质干细胞移植对脊髓损伤区域炎症反应的影响[J].广东医学,2020,41(1): 5-8.
[61] LIU W, RONG Y, WANG J, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation.2020;17(1): 47.
|